Monsanto 2Q: Seed Sales Growth Fails To Lift Stock
Monsanto’s second quarter earnings beat the analyst consensus, with sales for the genetically-modified seed producer up over the same period last year. However investors reversed their sentiment on the stock Wednesday, possibly as a result of the company’s soft outlook for 2011.
Shares fell 4.3% after the earnings Wednesday morning.
No comments:
Post a Comment